- Meeting abstract
- Open Access
Testosterone regulates Arp2/3 expression by DNA methylation in hippocampus
© Zhou et al; licensee BioMed Central Ltd. 2012
- Published: 7 February 2012
- Adult Brain
- Testosterone Replacement
- Promoter Methylation Status
- Actin Nucleation
The Arp2/3 complex is a seven-protein assembly that is critical for actin nucleation and branching in cells. Although some DNA methylation patterns are altered by steroid hormone exposure in the developing brain, less is known about how changes in steroid hormone levels influence Arp2/3 complex DNA methylation patterns in the adult brain. Steroid hormones act in the adult brain to regulate gene expression. Specifically, the expression of the Arp2 within adult brain is dependent upon testosterone exposure.
Castration dramatically reduces and testosterone replacement restores Arp2 expression in hippocampus. As decreases in mRNA expression are associated with increases in DNA promoter methylation, we explored the hypothesis that Arp2 expression in the adult brain is maintained through sustained epigenetic modifications of the Arp2 gene promoter. We find that castration of adult male rats resulted in decreased Arp2 mRNA expression and increased methylation of specific CpG sites within the Arp2 promoter in the hippocampus. Similarly, castration significantly increased estrogen receptor α (ERα)/androgen receptor(AR) mRNA expression and decreased ERα promoter methylation within the hippocampus. These changes were prevented by testosterone replacement.
This suggests that the Arp2 DNA promoter methylation status of some steroid responsive genes in the adult brain is actively maintained by the presence of circulating steroid hormones. The maintenance of methylated states of some genes in the adult brain by the presence of steroid hormones may play a role in the cytoskeleton systems.
This work was supported by the National Natural Science Foundation of China (NSFC; Grants No.30973145), Doctoral Fund of Ministry of Education (20090001110058) and the National High Technology Research and Development Program of China (973 Program, No. 2012CB911004).
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.